<![CDATA[Fixed-Duration Combinations and MRD-Guided Therapy as Emerging Priorities in CLL]]>

ConferenceNeutral

AI Analysis

Summary

At SOHO 2026, Dr. Julie M. Vose discussed emerging treatment priorities in chronic lymphocytic leukemia, highlighting patient and physician preference for fixed-duration therapy and MRD-guided approaches.

Importance:3/10

Sentiment:

0.00

CLLchronic lymphocytic leukemiafixed-duration therapyMRD-guided therapySOHO 2026treatment paradigm

Related Companies

$GTHP

Read the original article

Published by Cancer Network on September 18, 2026 6:00 PM

Read Original